نتایج جستجو برای: nonalbicans candida spp

تعداد نتایج: 78917  

2014
VILAS A. KAMBLE

The antimicrobial property of volatile aromatic oils from medicinal as well as other edible plants has been recognized since antiquity. Candida species are an important cause of opportunistic infections in the oral cavity of immunocompromised patients and vaginal candidiasis. The antifungal activity of the essential oil of Cinnamomum cassia (cassia oil) was investigated against 75 clinical isol...

Journal: :Journal of clinical microbiology 2006
N Isham M A Ghannoum

Candida and Aspergillus spp., as well as other filamentous molds, have increasingly been reported as the causes of severe invasive fungal infections. We evaluated the new echinocandin aminocandin (AMN) for its antifungal activities against a range of fungal pathogens by determination of the MICs for the organisms. The MICs of the comparator drugs amphotericin B, caspofungin, micafungin, and vor...

Candida pneumonia is classified as primary when there is no other hematogenous manifestation of candidiasis. The infection is rare and usually is the result of aspiration. Secondary candida pneumonia, the most frequent presentation, is associated with hematogenous candidiasis. Among cancer patients, only 9% of pulmonary candidiasis cases were considered primary. Cardiovascular infections caused...

2015
Catarina L. Seabra Cláudia M. Botelho Ana C. N. Oliveira Mariana Henriques

Objectives: This research work intends to clarify the role of artificial saliva, in particularly the role of mucin, a salivary protein, on the surface properties and adhesion ability of Candida spp. oral clinical isolates to abiotic surfaces. Methods: Four oral clinical isolates of Candida spp. were used: two Candida albicans strains (AC; AM) and two Candida parapsilosis strains (AD; AM2). The ...

2016
Wan Harun Himratul-Aznita Che Omran Nor-Zulaila Khairuddin Nurul-Fatihah

Candida spp. is the most prevalent species causing systemic fungal infections. The effect of antifungal agents were screened in vitro and their synergism effect were determined between hydroxychavicol (HC) in association with commercialized antifungal drugs-amphotericin B (AMB), and 5-fluorocytosine (5-FC) alone and in combination against five different oral Candida spp. in their planktonic sta...

2013
Raid A Al-akeel Talat A El-kersh Yazeed A Al-Sheikh Ziab Zakey Al-Ahmadey

Biofilm formation by Candida species is a major contribute to their pathogenic potential.The aim of this study was to determine in vitro effects of EDTA, cycloheximide, and heparin-benzyl alcohol preservative on C. albicans (126) and non-albicans (31)vaginal yeast isolates biofilm formations and their susceptibility against three antifungal Etest strips. Results of the crystal violet-assay, ind...

Journal: :Archives of Iranian medicine 2012
Farideh Siavoshi Atefeh Tavakolian Alireza Foroumadi Negar Mohammad Hosseini Sadegh Massarrat Shahrzad Pedramnia Parastoo Saniee

BACKGROUND Non-antifungal drugs appear promising in treatment of opportunistic infections of Candida spp. that are often resistant to current antifungals. METHODS The broth macrodilution method (NCCLS M27-P document) was used to compare the antifungal activity of trifluoperazine, propranolol, and lansoprazole with that of ketoconazole and amphotericin B, using 50 yeast isolates from the GI tr...

داعی‌قزوینی, روشنک, رضایی, ساسان, زینی, فریده, صف آرا, مهین, طاهرزاده, نرگس سادات, محمودی, محمود, نیری, فاطمه سادات, کدیور, ملیحه, کردبچه, پریوش,

Background: Over the last two decades invasive candidiasis has become an increasing problem in neonatal intensive care units (NICUs). Colonization of skin and mucous membranes with Candida spp. is important factor in the pathogenesis of neonatal infection and several colonized sites are major risk factors evoking higher frequencies of progression to invasive candidiasis. The aim of this study w...

2016
Sachin C. Deorukhkar Santosh Saini

Health care associated infection (HCAI) has a propensity to thwart and decelerate the every effort of clinician taken towards patient care. In recent years HCAIs due to Candida spp. are increasing at an alarming rate. Candida spp. is now considered as the third or fourth most common cause of HCAIs in the United States, out numbering all Gram negative bacilli. Over the past few decades, the spec...

2017
Elizabeth L Berkow Shawn R Lockhart

Candida albicans and the emerging non-albicans Candida spp. have significant clinical relevance among many patient populations. Current treatment guidelines include fluconazole as a primary therapeutic option for the treatment of these infections, but it is only fungistatic against Candida spp. and both inherent and acquired resistance to fluconazole have been reported. Such mechanisms of resis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید